Related by context. Frequent words. (Click for all words.) 57 THERAPEUTICS 56 RESOURCES CORP. 55 THE TREND CONTINUES LOWER 55 ISOCOUNTRY3 55 THE TREND CONTINUES DOWN 54 WEEK HIGH RECENTLY ECLIPSED 54 THE TREND CONTINUES HIGHER 54 Guides FY# Quick Facts 53 GOLD INC. 53 SHARES COULD PULLBACK 53 PHARMACEUTICALS 53 SMARTREND DETECTS CONTINUED SELLING 53 THE WINNING STREAK 53 DOWNTREND SPOTTED IN SHARES 53 ACADIA Pharmaceuticals 53 DETECTS UNUSUAL ACTIVITY IN 53 COMPOSITE 52 RELEASES ITS QUARTERLY NUMBERS 52 REACHES INITIAL SUPPORT LEVEL 52 THE TREND CONTINUES UP 51 #.#X ABOVE AVERAGE VOLUME 51 SMARTREND RESEARCH REPORT AVAILABLE 51 IT REPORTS EARNINGS 51 RESOURCES LIMITED 51 ABOVE AVERAGE VOLUME 51 SMARTREND DETECTS CONTINUED BUYING 51 VOLUME WATCH FOR PULLBACK 51 BREAKS THROUGH SUPPORT 51 EMRG 51 PHARM 51 NASDAQ SHPGY 51 SHARES COULD POTENTIALLY PULLBACK 51 NTQ 51 RU EUROPE EEU EMRG 51 IIROC Halt 50 IIROC Resume 50 WEEK HIGH EXCEEDED IN 50 BIOTECHNOLOGY 50 BREAKS THROUGH RESISTANCE AT 50 OFFERS INVESTORS BETTER VALUE 50 Senesco Technologies 50 SET TO PULLBACK AFTER 50 CYTR 50 ARE MOVING HIGHER ON 50 CROSSES PIVOT POINT RESISTANCE 49 VOLUME WATCH FOR POTENTIAL 49 WITH THE LOWEST 49 APPROACHES NEW UPSIDE TARGET 49 YESTERDAY 'S RALLY OF 49 REACHES INITIAL RESISTANCE LEVEL 49 TO PULLBACK AFTER GAINING 49 SURGES 49 AXU 49 Fibrocell Science Inc. 49 APPROACHES NEW DOWNSIDE TARGET 48 PULLBACK 48 Transcept Pharmaceuticals 48 Calls Purchased 48 Lexicon Pharmaceuticals 48 INSM 48 Barrier Therapeutics Inc. 48 TSX SYMBOL 48 Files Shelf Registration Statement 48 Synergy Pharmaceuticals 48 ICON plc 48 HIGH SHARE PRICE TODAY 47 LLC Mgr 47 AGII 47 PZG 47 Explore Strategic Alternatives 47 BOOST UP 47 RHHBY 47 ENZN 47 Idera Pharmaceuticals 47 ALTERNATE 47 % SELL OFF 46 Cyclacel Pharmaceuticals 46 IART 46 Presents Positive 46 PROVISIONS 46 Emisphere Technologies 46 Announces FDA Clearance 46 Anika Therapeutics 45 ENTITY 45 MAY 6TH CRASH LOW 45 HOLDINGS 45 INSTRUMENT 45 PRECISION 45 Technol 45 MEOH 45 ASST 45 CORP NYSE 45 Regains Compliance With 45 CRME 45 ImmunoCellular Therapeutics 45 EXK 45 TSX VEN 45 QLTI 45 TRGT 45 ALXN 44 Biocompatibles International